Anti-NaPi2b/SLC34A2 Antibody (Upifitamab)
Catalog No.
F1445
Anti-NaPi2b/SLC34A2 Antibody (Upifitamab)
Featured Products
Upifitamab is aADC Antibody (naked antibody of upifitamab rilsodotin) can be used for the synthesis of antibody-conjugated active molecules (ADC). Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in the study of ovarian cancer, especially platinum-resistant recurrent ovarian cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.74 kDa
Dry ice
2254118-43-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Upifitamab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O95436
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human SLC34A2 (188 361aa) Fc at 2 ug/mL can bind Anti-NaPi2b/SLC34A2 Antibody (Upifitamab)
NaPi2b / SLC34A2
Please avoid freeze-thaw cycles.